Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.
Clarke MO, Chen X, Cho A, Delaney WE 4th, Doerffler E, Fardis M, Ji M, Mertzman M, Pakdaman R, Pyun HJ, Rowe T, Yang CY, Sheng XC, Kim CU.
Clarke MO, et al. Among authors: chen x.
Bioorg Med Chem Lett. 2011 Jun 15;21(12):3568-72. doi: 10.1016/j.bmcl.2011.04.125. Epub 2011 May 3.
Bioorg Med Chem Lett. 2011.
PMID: 21601450